Cline Scientific Files New Patent Application for CellRACE Cancer Diagnostic Product
Cline Scientific AB (“Cline” or “The Company”) has submitted a new patent application that covers the device and method associated with Cline’s cancer diagnostic product, CellRACE. The method is based on Cline’s patented nanogradient surfaces and the development carried out by Cline-acquired company Liv Diagnostics. This patent application is the first submitted as part of the CellRACE patent protection strategy and, when granted, will provide Cline strong protection for the product. The device and method developed by Cline enable CellRACE to revolutionize cancer diagnosis and treatment